Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Mauna Kea Technologies
  6. Summary
    MKEA   FR0010609263

MAUNA KEA TECHNOLOGIES

(MKEA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
11/22/2021 11/23/2021 11/24/2021 11/25/2021 11/26/2021 Date
0.8(c) 0.8(c) 0.896(c) 0.87(c) 0.812(c) Last
106 545 73 353 747 292 272 452 302 062 Volume
-1.72% 0.00% +12.00% -2.90% -6.67% Change
More quotes
Estimated financial data (e)
Sales 2021 7,26 M 8,21 M 8,21 M
Net income 2021 -15,0 M -17,0 M -17,0 M
Net Debt 2021 28,0 M 31,7 M 31,7 M
P/E ratio 2021 -1,99x
Yield 2021 -
Sales 2022 10,1 M 11,5 M 11,5 M
Net income 2022 -14,9 M -16,9 M -16,9 M
Net Debt 2022 42,2 M 47,8 M 47,8 M
P/E ratio 2022 -2,01x
Yield 2022 -
Capitalization 35,9 M 40,7 M 40,7 M
EV / Sales 2021 8,81x
EV / Sales 2022 7,72x
Nbr of Employees 99
Free-Float 96,9%
More Financials
Company
Mauna Kea Technologies SAS is a medical device company based in France. The Company focuses on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases thanks to real time in vivo microscopic visualization. The CompanyÔÇÖs flagship product is Cellvizio, a confocal laser endomicroscopy platform using microprobes and needles. This technological platform enables to view tissues at... 
More about the company
Ratings of Mauna Kea Technologies
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about MAUNA KEA TECHNOLOGIES
10/28Mauna Kea Technologies SA Revises Earnings Guidance for the Full Year 2021
CI
10/05GLOBAL MARKETS LIVE : Facebook, AB InBev, Qantas, Tesco, Swiss Re...
10/04MAUNA KEA TECHNOLOGIES : Announces 5 Communications Highlighting the Clinical Value of Cel..
PU
10/04Mauna Kea Technologies Announces 5 Communications Highlighting the Clinical Value of Ce..
CI
09/23Mauna Kea Technologies Sa Reports Earnings Results for the Half Year Ended June 30, 202..
CI
09/23MAUNA KEA TECHNOLOGIES : reports first half 2021 financial results
PU
09/20GLOBAL MARKETS LIVE : Universal Music Group, China Evergrande, ENI, Prudential, Microsoft...
09/20MAUNA KEA TECHNOLOGIES : Initiates $15 Million Capital Raise for Two Investors
MT
09/20MAUNA KEA TECHNOLOGIES : Johnson & Johnson Enter Lung Cancer Research Collaboration
MT
09/20Mauna Kea Technologies Announces New Clinical Study and Research Collaboration Agreemen..
CI
08/25GLOBAL MARKETS LIVE : Kering, Delta Air Lines, Pfizer, Moderna, Sony...
08/24Mauna Kea Technologies Receives U.S. FDA 510(k) Clearance of its Next-Generation Cellvi..
CI
07/23GLOBAL MARKETS LIVE : Intel, HoneyWell, American Express, Visa, Twitter...
07/22Mauna Kea Technologies Announces Sales Results for the Second Quarter and First Half Ye..
CI
07/22Mauna Kea Technologies SA Provides Earnings Guidance for the Twelve Months Ending Decem..
CI
More news
News in other languages on MAUNA KEA TECHNOLOGIES
11/18MAUNA KEA : une nouvelle publication dope la valeur
11/04MAUNA KEA : Armistice Capital sous les 10% de capital
11/03MAUNA KEA TECHNOLOGIES : parmi les plus fortes hausses du SRD à la mi-séance du mercredi 3..
10/29Mauna Kea, parmi les plus fortes baisses du SRD à la clôture du vendredi 29 octobre 202..
10/29Mauna Kea, parmi les plus fortes baisses du SRD à la mi-séance du vendredi 29 octobre 2..
More news
Chart MAUNA KEA TECHNOLOGIES
Duration : Period :
Mauna Kea Technologies Technical Analysis Chart | MKEA | FR0010609263 | MarketScreener
Technical analysis trends MAUNA KEA TECHNOLOGIES
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 0,81 €
Average target price 2,00 €
Spread / Average Target 146%
EPS Revisions
Managers and Directors
Robert L. Gershon Chief Executive Officer & Director
Christophe Lamboeuf CFO & Deputy Chief Executive Officer
Sacha Loiseau Chairman
Franšois Lacombe Chief Scientific Officer
Aline Criton Chief Clinical & Regulatory Affairs Officer
Sector and Competitors
1st jan.Capi. (M$)
MAUNA KEA TECHNOLOGIES-38.30%41
SARTORIUS AG49.28%42 386
BIOTAGE AB (PUBL)89.21%1 906
REVENIO GROUP OYJ9.24%1 652
VAREX IMAGING CORPORATION76.68%1 162
CELLAVISION AB (PUBL)15.90%932